Chemillennium International Limited.

Hong Kong, S.A.R., China

Chemillennium International Ltd is your Global API Sourcing Specialist, with over 21 years of proven expertise to support Generic Drug manufacturers make Quality Products Affordable & Available. Making Possibilities Real & Causing Value for Life are at the core of our culture. Headquartered in Hong Kong since 1999, We've continued to work with Medium to Large Generic Pharmaceutical manufacturers globally, to support their API requirements for their Production and Projects. Our sourcing capabilities and strength comes from our commitment to fulfilling the possibility of your project combined with, our Global network of Quality API manufacturers. Networked with over 100 Regulated Manufacturers of APIs in Europe, India, China, Korea, Taiwan , Japan & USA, We are well placed to connect your project with the most appropriate API source. Our AI-driven sourcing system, has proven data analysis and research capabilities, to make you competitive. With over 300 clients globally and an ever expanding clientbase, its our unqiue sourcing approach that generates huge increase in competitive abiliity and efficiency for our clients. Our Teams are especially beneficial in the following two situations : 1. Making Current Products Competitive : To support generating competitive ability & Supply-Chain risk management by Alternate Vendor Development. 2. Developing / Registering New Drugs to Market : To support New Source Validation for New Product Development , Technology scouting and Dossier In-licensing/ Development support. With a Complete In-House Data Analysis & Regulatory Affairs Team, We are fully capable to support our clients, in navigating the entire process of making possibilites real.

Learn
More

Daegu Gyengbuk Free Economic Zone in Korea It is a kind of special economic zone in Daegu, Gyeongbuk province in Korea for foreign investment using Korean knowledge-based industries and infrastructures differentiated from the existing special zones focusing on logistics. It is adjacent to China, Japan, and Russia, with 51 major global cities over 1 million population within 4 hours of flight distance, and has a mega-sized intelligence-based service and manufacturing market.

Learn
More

Rx-360

United States

The Rx-360 mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of its materials. With a focus on building strong partnerships between pharmaceutical manufacturers and suppliers, Rx-360’s goal is to ensure the integrity of supply chains through on-site auditing. We are a community of life-science and medical device thought leaders committed to driving positive change within the industry.

Learn
More

TUL was established in Hong Kong in 1990, which is a leading integrated pharmaceutical group company in China that researches, develops, manufactures, markets bulk medicines and intermediate products as well as finished products. Through more than 2 decades of development in China, TUL has grown into one of the largest antibiotics manufacturers in the world and also the largest insulin products base in China. TUL has 6 subsidiary plants nationwide across China altogether with employees totaling more than 10,000, whose products have been sold in 5 continents up to 60 countries. June 15,2007 saw TUL successfully listed in Hong Kong exchange(03933.HK. So far, Dozens of products by TUL have passed certification of EU-GMP, FDA, China GMP. Looking ahead, TUL stays committed to be in a pursuit of an objective of provision of superior quality medicines and products, aspiring with a dedication to promotion of the well-being of millions of people within China and around the world. We are energized by our pursuit, because we know significance of the mission we pursue: “ to make life more valuable”.

Learn
More
  • Chemillennium International Limited.

    Country/Region: Hong Kong, S.A.R., China

    Connect E-Meeting

    Chemillennium International Ltd is your Global API Sourcing Specialist, with over 21 years of proven expertise to support Generic Drug manufacturers make Quality Products Affordable & Available. Making Possibilities Real & Causing Value for Life are at the core of our culture. Headquartered in Hong Kong since 1999, We've continued to work with Medium to Large Generic Pharmaceutical manufacturers globally, to support their API requirements for their Production and Projects. Our sourcing capabilities and strength comes from our commitment to fulfilling the possibility of your project combined with, our Global network of Quality API manufacturers. Networked with over 100 Regulated Manufacturers of APIs in Europe, India, China, Korea, Taiwan , Japan & USA, We are well placed to connect your project with the most appropriate API source. Our AI-driven sourcing system, has proven data analysis and research capabilities, to make you competitive. With over 300 clients globally and an ever expanding clientbase, its our unqiue sourcing approach that generates huge increase in competitive abiliity and efficiency for our clients. Our Teams are especially beneficial in the following two situations : 1. Making Current Products Competitive : To support generating competitive ability & Supply-Chain risk management by Alternate Vendor Development. 2. Developing / Registering New Drugs to Market : To support New Source Validation for New Product Development , Technology scouting and Dossier In-licensing/ Development support. With a Complete In-House Data Analysis & Regulatory Affairs Team, We are fully capable to support our clients, in navigating the entire process of making possibilites real.

  • Daegu Gyeongbuk Free Economic Zone

    Country/Region: Republic of Korea

    Video Connect E-Meeting

    Daegu Gyengbuk Free Economic Zone in Korea It is a kind of special economic zone in Daegu, Gyeongbuk province in Korea for foreign investment using Korean knowledge-based industries and infrastructures differentiated from the existing special zones focusing on logistics. It is adjacent to China, Japan, and Russia, with 51 major global cities over 1 million population within 4 hours of flight distance, and has a mega-sized intelligence-based service and manufacturing market.

  • The United Laboratories International Holding Ltd.

    Country/Region: China Mainland

    Connect E-Meeting

    TUL was established in Hong Kong in 1990, which is a leading integrated pharmaceutical group company in China that researches, develops, manufactures, markets bulk medicines and intermediate products as well as finished products. Through more than 2 decades of development in China, TUL has grown into one of the largest antibiotics manufacturers in the world and also the largest insulin products base in China. TUL has 6 subsidiary plants nationwide across China altogether with employees totaling more than 10,000, whose products have been sold in 5 continents up to 60 countries. June 15,2007 saw TUL successfully listed in Hong Kong exchange(03933.HK. So far, Dozens of products by TUL have passed certification of EU-GMP, FDA, China GMP. Looking ahead, TUL stays committed to be in a pursuit of an objective of provision of superior quality medicines and products, aspiring with a dedication to promotion of the well-being of millions of people within China and around the world. We are energized by our pursuit, because we know significance of the mission we pursue: “ to make life more valuable”.

  • Anhui Jinhe Industrial Co., Ltd

    Country/Region: China Mainland

    Anhui Jinhe Industrial Co., Ltd. is a worldwide leader in the field of high-end sweeteners and flavorings. With a long history of leding the markets of Acetyl, Maltol, Ethyl Maltol and MCP, Anhui Jinhe became one of sucralose (a world's advanced and healthy sweetener) manufacturers of in 2017.

  • China Chinopharma Ltd.

    Country/Region: China Mainland

    China Shanghai Chinopharma Ltd (CSC) is one of the biggest, mature, professional and specialized corporate agents for domestic and worldwide manufacturers of Active Pharmaceutical Ingredients, Drug Products, Intermediates and Natural plant extracts. Base on extensive and solid market network, CSC builds and keeps long-term, mutually beneficial and strong cooperation relationship with many first-class chemical and pharmaceutical enterprises in the world. CSC has successfully introduced lots of oversea high quality APIs, Formulations into China, especially from India, but also exports excellent pharmaceutical of domestic counterparts to all over the world. Please see our “Business”. CSC has long years’ successful experience in registration work for abroad partners’ pharmaceutical products into China, depending on its professional and excellent intellectual, advanced laboratory equipments, precise DMF Data rechecking and modifying function, several years’ successful experiences, high efficient administration in the registration. CSC also supplies a series of services, such as getting Sale License in different countries, supplying accurate and scientific marketing report, supplying patent and brand name application and so on.

  • Shanghai Forxine Pharmaceutical.Co.,Ltd.

    Country/Region: China Mainland

    Forxine, Benefit the society, Revitalize the Chinese nation. Forxine's core value is "For the better of the optimistic struggles, Make chemistry more popular". Forxine was founded in 2014 and formally operated in 2015, located in Xinzhuang industrial park, Minhang district, Shanghai. Forxine put forward the concept of "Borane Chemistry" and solved the technical problem of industrialization of Borane Chemistry. Forxine is a pharmaceutical technology enterprise with boron technology as its core business. Forxine owns a famous boron technology brand , 10000 square meters of boron technology R&D centre and production base. Forxine has achieved rapid development through technological advantages and internet marketing since founded. Forxine already has more than 1000 customers and strategic partners. Boron technology, a creative new technology to construct biopharma molecules, has multiple advantages such as green and environmental protection, stable quality, low cost and high efficiency. Boron technology will become the core technology which will be widely used in the field of biopharma in future. Forxine boron technology and products are in the international advanced position. In 2015, we got innovation fund of Minhang District. In 2016, we are awarded the top ten of Shanghai youth innovation and entrepreneurship competition. In 2017, we got innovation fund of Shanghai. In 2018, we were recognized as a high-tech enterprise in Shanghai. In 2019, we are identified as the "Small Giant" technology enterprise in minhang district, Shanghai. Forxine is a team of "Integrity, Unity, Win-win, Development", more than 60% of our members are from "985" ,"211" universities which are widely considered as the best universities in China. Our cultural concept is "Integrity-based, Optimistic struggle, Technical priority". Forxine's business faith is "Customer achievement, Fair starting, Legitimate operation". Forxine provides customers with "Good and Inexpensive" technologies and products, and provides "Technology-first" platform for optimistic strivers to benefit them, and we repay the society through continuously growing tax payment.

  • ATTO (Chongqing)CO., LTD.

    Country/Region: China Mainland

    Atto Co., Ltd. the company's main business is all kinds of fine chemicals, pharmaceutical intermediates, chemical products, electronic chemicals, etc., the main customer groups are Japan's leading large pharmaceutical enterprises, They are sold at home and abroad. We have a cooperative relationship with more than 100 chemical manufacturers, research institutes and development and manufacturing bases in China and South Korea. We can carry out a series of business, including new project development, small amount of sample manufacturing, commercial large-scale commissioned production, etc. Atto Shanghai Office mainly seeks reliable suppliers for major customers in China, For the headquarters to develop the market to do strong support services.

  • Metrochem API

    Country/Region: India

    Metrochem API Pvt Ltd was founded by Dr. N.V. Rao (PhD in Organic Chemistry) in the year 2004, with a grand vision of being the “most preferred supply partner to pharmaceutical customers worldwide” through timely deliveries, quality products and stellar customer service. Over the last 15 years, Metrochem API Private Limited has evolved into one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi finished Formulations) and Intermediates. Our strong commitment to providing quality products is boasted by in-depth industry knowledge, a well-qualified team of professionals, as well as hi-tech and advanced infrastructure. We have 6 manufacturing facilities in Hyderabad and Visakhapatnam, catering to our API, Pellet and Intermediate needs. We have a 2500 strong workforce manning these facilities. Our manufacturing facilities are approved by several international regulatory bodies such as ISO 9001-2015, USFDA, WHO: GMP, PMDA, COFEPRIS and KFDA. Our R&D center, sprawling across a 20,000 sqft campus in Hyderabad, is the backbone of our success. Till date we have commercialized over 350 products and we have more than 100 products in our pipeline. Our product brochure is attached for your reference.

  • Rx-360

    Country/Region: United States

    The Rx-360 mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of its materials. With a focus on building strong partnerships between pharmaceutical manufacturers and suppliers, Rx-360’s goal is to ensure the integrity of supply chains through on-site auditing. We are a community of life-science and medical device thought leaders committed to driving positive change within the industry.

  • SQH Technology Development Co., Ltd

    Country/Region: China Mainland

    SQH Technology Development Co., Ltd is a professional manufacturer and solutions’ provider in the field of infusion plastic bottle packaging, founded in 2007. We not only offer single machine solutions, but also to turnkey project. With our devotion in research and development, combining our rich experiences in production and profession on services, we have provided perfect solutions for our clients and got a good reputation from them. Our customers included Europ, India, Malaysia, Vietnam, Turkey, Korea, Ukraine and most of cities in China.

Copyright 2006-2021 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by
×